16.04.2015 • NewsManufacturingRentschler BiopharmaGE

GE Healthcare Life Sciences and Rentschler Mark Handover

GE Healthcare Life Sciences has handed over its 1000th ÄKTAprocess to Rentschler Biotechnologie for use in the expanded biopharmaceutical manufacturing capabilities Rentschler has established in Laupheim, Germany.

The equipment supplied by GE features an automated process and manufacturing scale chromatography system. The offshoot of the US conglomerate said its biomanufacturing technologies such as the XDR 2000L bioreactor, the associated seed trains of 50, 200 and 500 L as well as the new ÄKTAprocess, which will be used in the reactor, all play a key role in Rentschler's new single-use manufacturing line.

Peter Rogge, vice president of USP Production at Rentschler, said the new line "will further enhance our ability to deliver high quality projects for companies around the globe," adding that the GE technology is also enabling an increase in Europe of next-generation manufacturing capabilities.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.